baclofen sold brand name lioresal among others medication used treat muscle spasticity spinal cord injury multiple may also used hiccups muscle spasms near end offlabel treat alcohol use opioid withdrawal taken orally swallowed mouth intrathecal pump delivered spinal canal via implantable pump also sometimes used transdermally applied topically skin combination gabapentin clonidine prepared compounding common side effects include sleepiness weakness serious side effects may occur baclofen rapidly stopped including seizures use pregnancy unclear safety use breastfeeding probably believed work decreasing levels certain adverse effects safety profile associated baclofen combined sedative drugs example alcohol benzodiazepines baclofen approved medical use united states available generic commonly prescribed medication united states million baclofen primarily used treatment spastic movement disorders especially instances spinal cord injury cerebral palsy multiple use people stroke parkinsons disease intrathecal baclofen used severe spasticity spinal cord origin refractive maximum doses oral antispasmodic agents experience intolerable side baclofen also used treatment sleeprelated painful baclofen sometimes used offlabel treatment alcohol use disorder reduce risk relapse increase number days person go without drinking alcohol abstinence also sometimes used treatment opioid withdrawal symptoms may superior purpose morecommonly used adverse effects include drowsiness dizziness weakness fatigue headache trouble sleeping nausea vomiting urinary retention discontinuation baclofen associated withdrawal syndrome resembles benzodiazepine withdrawal alcohol withdrawal withdrawal symptoms likely baclofen administered intrathecally long periods time couple months occur low high severity baclofen withdrawal depends rate discontinued thus minimise withdrawal symptoms dose tapered slowly discontinuing baclofen therapy abrupt withdrawal likely result severe withdrawal symptoms acute withdrawal symptoms eased completely reversed reinitiating therapy withdrawal symptoms may include auditory hallucinations visual hallucinations tactile hallucinations delusions confusion agitation delirium disorientation fluctuation consciousness insomnia dizziness nausea inattention memory impairments perceptual disturbances itching anxiety depersonalization hypertonia hyperthermia higher normal temperature without infection formal thought disorder psychosis mania mood disturbances restlessness behavioral disturbances tachycardia seizures tremors autonomic dysfunction hyperpyrexia fever extreme muscle rigidity resembling neuroleptic malignant syndrome rebound baclofen standard dosing appear possess addictive properties associated degree drug euphoria however listed common common sideeffect baclofen bnf cases abuse baclofen reasons attempted contrast baclofen another gabab receptor agonist γhydroxybutyric acid ghb associated euphoria abuse effects likely mediated activation gabab receptor rather activation ghb baclofen possesses sedative anxiolytic reports overdose indicate baclofen may cause symptoms including vomiting general weakness sedation respiratory insufficiency seizures unusual pupil sizeclarification needed itching hypothermia bradycardia cardiac conduction abnormalities hypertension hyporeflexia coma sometimes mimicking brain overdose may require intubation length mechanical ventilation required may correlate serum baclofen levels shortly ingestion symptoms may persist even point serum baclofen levels chemically baclofen derivative neurotransmitter γaminobutyric acid gaba believed work activating agonizing gaba receptors specifically gabab beneficial effects spasticity result actions brain spinal baclofen produces effects activating gabab receptor similar drug phenibut also activates receptor shares effects baclofen postulated block monoandpolysynaptic reflexes acting inhibitory ligand inhibiting release excitatory neurotransmitters however baclofen significant affinity ghb receptor known abuse agonism gabab receptor responsible baclofens range therapeutic properties similarly phenibut βphenylgaba well pregabalin βisobutylgaba close analogues baclofen baclofen found block subunitcontaining voltagegated calcium channels however weaker relative phenibut action ki μm r sphenibut μm moreover baclofen range potent weight agonist gabab receptor comparison phenibut accordance used far lower relative dosages actions baclofen subunitcontaining vgccs likely clinically drugreward addiction baclofens mechanism action thought affect mesolimbic dopamine pathway specifically leading decrease dopamine release associated gabab receptor activation gabab receptor agonist activity may decrease inhibit alcohols ability activate fire dopaminergic neurons following exposure alcohol baclofens mechanism action thought mediated musclerelaxing sedative properties however evidence suggest gabab receptoractivation limbus may also reduce feelings anxiety people alcohol use drug rapidly absorbed oral administration widely distributed throughout body biotransformation low drug predominantly excreted unchanged halflife baclofen roughly hours therefore needs administered frequently throughout day control spasticity appropriately baclofen white offwhite mostly odorless crystalline powder molecular weight gmol slightly soluble water slightly soluble methanol insoluble chloroform historically baclofen designed drug treating epilepsy first made cibageigy swiss chemist heinrich keberle effect epilepsy disappointing found certain people spasticity decreased introduced treatment certain form spasticity approved us food drug administration fda intrathecal baclofen first introduced treat severe spinal spasticity administration route aimed avoid supraspinal side book le dernier verre translated literally last glass end addiction frenchamerican cardiologist olivier ameisen described treated alcoholism baclofen inspired book anonymous donor gave university amsterdam netherlands initiate clinical trial highdose baclofen ameisen called since trial concluded summary current study find evidence positive effect either low high doses baclofen ad patients however exclude possibility baclofen effective medication treatment severe heavy drinking ad patients responding accepting routine psychosocial baclofen administered orally intrathecally directly cerebral spinal fluid using pump implanted skin transdermally part painrelieving musclerelaxing topical cream mix also containing gabapentin clonidine prepared compounding intrathecal pumps offer much lower doses baclofen designed deliver medication directly spinal fluid rather going digestive blood system first drug concentration cerebrospinal fluid times greater given orally achieved route versus time blood concentration levels almost undetectable thus minimizing side besides spasticity intrathecal administration also used patients cerebral multiple sclerosis severe painful spasms controllable oral baclofencitation needed pump administration test dose first injected spinal fluid assess effect successful relieving spasticity chronic intrathecal catheter inserted spine abdomen attached pump implanted abdomens skin usually ribcagecitation needed pump computercontrolled automatic dosage reservoir replenished percutaneous injectioncitation needed pump also replaced every five years battery changedcitation needed synonyms include chlorophenibut brand names include beklo baclodol flexibac gablofen kemstro liofen lioresal lyflex clofen muslofen bacloren baklofen sclerofen pacifen others baclofen studied treatment evidence conclusive enough recommend use french drug agency ansm issued temporary recommendation allowing use baclofen baclofen received marketing authorization use alcoholism treatment agency treatments studied along naltrexone sorbitol charcotmarietooth disease cmt hereditary disease causes peripheral also studied cocaine baclofen muscle relaxants studied potential use persistent baclofen misuse toxicity use suicide attempts among adults us httpsenwikipediaorgwikibaclofen